Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 4 25 20 SULFITE FREE IN DEXTROSE 20 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 4 25 20 SULFITE FREE IN DEXTROSE 20 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER vs KABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER is a parenteral nutrition solution. Dextrose provides caloric energy via glycolysis and oxidative phosphorylation. Amino acids (4.25%) serve as substrates for protein synthesis, gluconeogenesis, and metabolic pathways. Electrolytes maintain osmotic balance and cellular function.
Kabiven is a parenteral nutrition formulation that provides a balanced mixture of amino acids, dextrose, and lipids to meet nutritional requirements. The amino acids serve as building blocks for protein synthesis, dextrose provides a carbohydrate source for energy, and lipids supply essential fatty acids and additional energy. Electrolytes are included to maintain fluid and electrolyte balance.
Intravenous infusion: 4.25% amino acids with 20% dextrose. Typical adult dose: 1-2 L per day via central line, infused at a rate of 50-100 mL/hour, adjusted based on metabolic needs and tolerance.
Intravenous infusion. Adult dose based on nutritional needs: typically 0.8-1.5 g amino acids/kg/day, 0.8-1.5 g lipids/kg/day, and 2-4 g dextrose/kg/day. Maximum infusion rate: 1.7 mL/kg/hour (Kabiven Peripher) or 2.6 mL/kg/hour (Kabiven Central).
None Documented
None Documented
Not applicable as a fixed formulation; individual components: glucose ~2-4 h, amino acids ~0.5-2 h depending on type.
Variable; amino acids: 0.5–1 h; lipids: 0.5–1 h (intralipid clearance); glucose: rapid. No true terminal half-life as a mixture.
Renal: ~95% as unchanged glucose and amino acids; minimal biliary/fecal.
Renal: <3% unchanged; primarily metabolized via protein catabolism; nitrogen excretion is renal (urea, ammonia); fat emulsion components are cleared by the reticuloendothelial system and metabolized. Biliary/fecal: negligible.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition